Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review
Frontiers in Pediatrics · 17.07.2023 · 11
DOI: 10.3389/fped.2023.1223191 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 17.07.2023. Verfasst von Sanya Thomas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Severe congenital neutropenia caused by jagunal homolog 1 ( JAGN1 ) mutation is a rare condition resulting from maturation arrest secondary to endoplasmic reticulum stress response from impaired neutrophil protein glycosylation. Here, we report a case of a 4-year-old boy who presented with a history of recurrent infections and manifestations, including recurrent intracranial hemorrhage. A review of similar cases reported in the literature indicates that a bleeding diathesis has not been previously described in these patients. We hypothesize that this newly described association of bleeding complications in this patient with JAGN1 mutation is secondary to defective glycosylation in the normal functioning of platelets or clotting factors. Recurrent infections with intracranial hemorrhage, new focal neurologic defects, or altered mental status in a child should warrant a suspicion for this immunodeficiency for the prompt initiation of treatment and prophylaxis for life-threatening infections or trauma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
- Harvard Medical School, Boston, MA, United States.
- Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
- Division of Hematology, Boston Children's Hospital and Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
- Division of Immunology, Boston Children's Hospital, Boston, MA, United States.
- Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Förderung
- NIAID NIH HHS
Zitieren
APA
Thomas, S., Guenther, G., Rowe, J. H., Platt, C. D., Shimamura, A., Levy, O., & Ganapathi, L. (2023). Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1223191
Vancouver
Thomas S, Guenther G, Rowe JH, Platt CD, Shimamura A, Levy O, et al. Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1223191
BibTeX
@article{Thomas2023,
author = {Thomas, Sanya and Guenther, Geoffrey and Rowe, Jared H and Platt, Craig D and Shimamura, Akiko and Levy, Ofer and Ganapathi, Lakshmi},
title = {Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review},
journal = {Frontiers in Pediatrics},
year = {2023},
volume = {11},
doi = {10.3389/fped.2023.1223191}
}
EUVIMED